{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T06:04:39Z","timestamp":1791266679844,"version":"4.1.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003100","name":"F\u00e9d\u00e9ration Fran\u00e7aise de Cardiologie","doi-asserted-by":"publisher","award":["75012"],"award-info":[{"award-number":["75012"]}],"id":[{"id":"10.13039\/501100003100","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004431","name":"Fondation de France","doi-asserted-by":"publisher","award":["75008"],"award-info":[{"award-number":["75008"]}],"id":[{"id":"10.13039\/501100004431","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vascular Pharmacology"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.vph.2015.04.007","type":"journal-article","created":{"date-parts":[[2015,4,26]],"date-time":"2015-04-26T04:59:09Z","timestamp":1430024349000},"page":"181-189","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Increased \u03b22-adrenergic vasorelaxation at the early phase of endotoxemic shock in rats"],"prefix":"10.1016","volume":"72","author":[{"given":"D.","family":"Roul","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Rozec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Andr\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Merlet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Tran Quang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Lauzier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Ferron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Blanloeil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Loirand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Sauzeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Gauthier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.vph.2015.04.007_bb0005","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1097\/00003246-200107000-00002","article-title":"Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care","volume":"29","author":"Angus","year":"2001","journal-title":"Crit Care Med"},{"issue":"4","key":"10.1016\/j.vph.2015.04.007_bb0010","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.jcrc.2014.03.028","article-title":"Myocardial depression in sepsis: from pathogenesis to clinical manifestations and treatment","volume":"29","author":"Antonucci","year":"2014","journal-title":"J Crit Care"},{"issue":"2","key":"10.1016\/j.vph.2015.04.007_bb0015","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/sj.bjp.0704867","article-title":"Beta 3-adrenoceptor in rat aorta: molecular and biochemical characterization and signalling pathway","volume":"137","author":"Rautureau","year":"2002","journal-title":"Br J Pharmacol"},{"issue":"11","key":"10.1016\/j.vph.2015.04.007_bb0020","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1164\/rccm.200306-816CC","article-title":"Hemodynamic instability in sepsis: bedside assessment by Doppler echocardiography","volume":"168","author":"Vieillard-Baron","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"issue":"9453","key":"10.1016\/j.vph.2015.04.007_bb0025","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0140-6736(04)17667-8","article-title":"Septic shock","volume":"365","author":"Annane","year":"2005","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.vph.2015.04.007_bb0030","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1056\/NEJMra002709","article-title":"The pathogenesis of vasodilatory shock","volume":"345","author":"Landry","year":"2001","journal-title":"N Engl J Med"},{"issue":"2 Pt 2","key":"10.1016\/j.vph.2015.04.007_bb0035","first-page":"H416","article-title":"Vascular effects of LPS in mice deficient in expression of the gene for inducible nitric oxide synthase","volume":"275","author":"Gunnett","year":"1998","journal-title":"Am J Physiol"},{"issue":"1","key":"10.1016\/j.vph.2015.04.007_bb0040","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/labinvest.3700366","article-title":"Lipopolysaccharide signaling in endothelial cells","volume":"86","author":"Dauphinee","year":"2006","journal-title":"Lab Invest"},{"issue":"9","key":"10.1016\/j.vph.2015.04.007_bb0045","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1097\/01.CCM.0000138558.16257.3F","article-title":"Persistent microcirculatory alterations are associated with organ failure and death in patients with septic shock","volume":"32","author":"Sakr","year":"2004","journal-title":"Crit Care Med"},{"issue":"8","key":"10.1016\/j.vph.2015.04.007_bb0050","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1038\/sj.bjp.0701335","article-title":"Intrarenal haemodynamics and renal dysfunction in endotoxaemia: effects of nitric oxide synthase inhibition","volume":"121","author":"Millar","year":"1997","journal-title":"Br J Pharmacol"},{"issue":"3","key":"10.1016\/j.vph.2015.04.007_bb0055","doi-asserted-by":"crossref","first-page":"H1129","DOI":"10.1152\/ajpheart.2001.280.3.H1129","article-title":"Vascular beta-adrenergic receptor system is dysfunctional after myocardial infarction","volume":"280","author":"Gaballa","year":"2001","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"12","key":"10.1016\/j.vph.2015.04.007_bb0060","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1042\/CS20070136","article-title":"Left ventricular hypertrophy induced by aortic banding impairs relaxation of isolated coronary arteries","volume":"113","author":"McGoldrick","year":"2007","journal-title":"Clin Sci (Lond)"},{"issue":"3","key":"10.1016\/j.vph.2015.04.007_bb0065","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1124\/jpet.108.146043","article-title":"The impact of alpha1-adrenoceptors up-regulation accompanied by the impairment of beta-adrenergic vasodilatation in hypertension","volume":"328","author":"Oliver","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"issue":"23","key":"10.1016\/j.vph.2015.04.007_bb0070","doi-asserted-by":"crossref","first-page":"5361","DOI":"10.1111\/bph.12853","article-title":"Alteration of vascular reactivity in heart failure: role of phosphodiesterases 3 and 4","volume":"171","author":"Hubert","year":"2014","journal-title":"Br J Pharmacol"},{"issue":"6","key":"10.1016\/j.vph.2015.04.007_bb0075","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1139\/y00-015","article-title":"Vascular beta-adrenoceptor function in hypertension and in ageing","volume":"78","author":"Werstiuk","year":"2000","journal-title":"Can J Physiol Pharmacol"},{"issue":"5","key":"10.1016\/j.vph.2015.04.007_bb0080","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.jcrc.2013.04.010","article-title":"Coagulopathy, catecholamines, and biomarkers of endothelial damage in experimental human endotoxemia and in patients with severe sepsis: a prospective study","volume":"28","author":"Ostrowski","year":"2013","journal-title":"J Crit Care"},{"issue":"5","key":"10.1016\/j.vph.2015.04.007_bb0085","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1365-2885.1996.tb00069.x","article-title":"Effect of pharmacological agonists on contractile responses in aortic rings derived from endotoxaemic rats","volume":"19","author":"Donaldson","year":"1996","journal-title":"J Vet Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.vph.2015.04.007_bb0090","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0031-6997(24)01495-9","article-title":"Vascular adrenoceptors: an update","volume":"53","author":"Guimaraes","year":"2001","journal-title":"Pharmacol Rev"},{"issue":"3","key":"10.1016\/j.vph.2015.04.007_bb0095","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.pharmthera.2005.12.002","article-title":"Beta3-adrenoceptors in the cardiovascular system: putative roles in human pathologies","volume":"111","author":"Rozec","year":"2006","journal-title":"Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.vph.2015.04.007_bb0100","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/j.1476-5381.2009.00074.x","article-title":"Investigation of the different adrenoceptor targets of nebivolol enantiomers in rat thoracic aorta","volume":"156","author":"Tran Quang","year":"2009","journal-title":"Br J Pharmacol"},{"issue":"1","key":"10.1016\/j.vph.2015.04.007_bb0105","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1172\/JCI38356","article-title":"The Rho\/Rac exchange factor Vav2 controls nitric oxide-dependent responses in mouse vascular smooth muscle cells","volume":"120","author":"Sauzeau","year":"2010","journal-title":"J Clin Invest"},{"issue":"4","key":"10.1016\/j.vph.2015.04.007_bb0110","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(\u2212Delta Delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"issue":"3","key":"10.1016\/j.vph.2015.04.007_bb0115","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1152\/jappl.1999.87.3.977","article-title":"Dobutamine as selective beta(1)-adrenoceptor agonist in in vivo studies on human thermogenesis and lipid utilization","volume":"87","author":"Schiffelers","year":"1999","journal-title":"J Appl Physiol"},{"issue":"1","key":"10.1016\/j.vph.2015.04.007_bb0120","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/chir.20874","article-title":"\u201cThe beta1-selective adrenoceptor agonist dobutamine\u201d: a fallacy being perpetuated","volume":"23","author":"Waldeck","year":"2011","journal-title":"Chirality"},{"issue":"2","key":"10.1016\/j.vph.2015.04.007_bb0125","doi-asserted-by":"crossref","first-page":"R57","DOI":"10.1186\/cc12585","article-title":"Dopexamine can attenuate the inflammatory response and protect against organ injury in the absence of significant effects on hemodynamics or regional microvascular flow","volume":"17","author":"Bangash","year":"2013","journal-title":"Crit Care"},{"issue":"10","key":"10.1016\/j.vph.2015.04.007_bb0130","doi-asserted-by":"crossref","first-page":"2868","DOI":"10.1172\/JCI39421","article-title":"Animal models of sepsis and sepsis-induced kidney injury","volume":"119","author":"Doi","year":"2009","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.vph.2015.04.007_bb0135","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1124\/jpet.106.108100","article-title":"A role for nitric oxide-mediated peroxynitrite formation in a model of endotoxin-induced shock","volume":"319","author":"Cuzzocrea","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"issue":"5 Suppl.","key":"10.1016\/j.vph.2015.04.007_bb0140","first-page":"e28","article-title":"Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP\/SCCM Consensus Conference Committee. American College of Chest Physicians\/Society of Critical Care Medicine. 1992","volume":"136","author":"Bone","year":"2009","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.vph.2015.04.007_bb0145","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1097\/00005373-199811000-00003","article-title":"Endotoxin differentially impairs receptor-mediated relaxation in rat isolated pulmonary and thoracic aortic vessels","volume":"45","author":"McIntyre","year":"1998","journal-title":"J Trauma"},{"issue":"2","key":"10.1016\/j.vph.2015.04.007_bb0150","first-page":"307","article-title":"Uncoupling of coronary microvascular beta 2-adrenoceptors by Escherichia coli endotoxemia","volume":"116","author":"Wang","year":"1994","journal-title":"Surgery"},{"issue":"1","key":"10.1016\/j.vph.2015.04.007_bb0155","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/sj.bjp.0702797","article-title":"Beta 3-adrenoceptor stimulation induces vasorelaxation mediated essentially by endothelium-derived nitric oxide in rat thoracic aorta","volume":"128","author":"Trochu","year":"1999","journal-title":"Br J Pharmacol"},{"issue":"4","key":"10.1016\/j.vph.2015.04.007_bb0160","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1111\/j.1476-5381.1994.tb13190.x","article-title":"Regional haemodynamic responses to acetylcholine, methoxamine, salbutamol and bradykinin during lipopolysaccharide infusion in conscious rats","volume":"112","author":"Waller","year":"1994","journal-title":"Br J Pharmacol"},{"issue":"5","key":"10.1016\/j.vph.2015.04.007_bb0165","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1097\/01.shk.0000228794.95302.c3","article-title":"Recruitment of functionally active heart beta2-adrenoceptors in the initial phase of endotoxic shock in pithed rats","volume":"26","author":"Godlewski","year":"2006","journal-title":"Shock"},{"issue":"9","key":"10.1016\/j.vph.2015.04.007_bb0170","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1007\/s00134-010-1839-z","article-title":"Effects of terbutaline on circulatory failure and organ dysfunction induced by peritonitis in rats","volume":"36","author":"Tsao","year":"2010","journal-title":"Intensive Care Med"},{"issue":"3","key":"10.1016\/j.vph.2015.04.007_bb0175","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s00011-003-1228-y","article-title":"Endotoxin-induced liver damage in rats is minimized by beta 2-adrenoceptor stimulation","volume":"53","author":"Izeboud","year":"2004","journal-title":"Inflamm Res"},{"issue":"2","key":"10.1016\/j.vph.2015.04.007_bb0180","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.hrtlng.2006.06.006","article-title":"Direct inotropic effect of the beta-2 receptor agonist terbutaline on impaired diaphragmatic contractility in septic rats","volume":"36","author":"Uzuki","year":"2007","journal-title":"Heart Lung"},{"issue":"3","key":"10.1016\/j.vph.2015.04.007_bb0185","first-page":"341","article-title":"Renal beta2-adrenoceptor blockade worsens the outcome of an induced Escherichia coli renal infection","volume":"23","author":"Nakamura","year":"2010","journal-title":"J Nephrol"},{"issue":"6","key":"10.1016\/j.vph.2015.04.007_bb0190","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1042\/CS20050088","article-title":"Adenoviral delivery of the beta2-adrenoceptor gene in sepsis: a subcutaneous approach in rat for kidney protection","volume":"109","author":"Nakamura","year":"2005","journal-title":"Clin Sci (Lond)"},{"issue":"10","key":"10.1016\/j.vph.2015.04.007_bb0195","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1097\/00003246-199810000-00012","article-title":"Dopexamine attenuates endotoxin-induced microcirculatory changes in rat mesentery: role of beta2 adrenoceptors","volume":"26","author":"Schmidt","year":"1998","journal-title":"Crit Care Med"},{"issue":"2","key":"10.1016\/j.vph.2015.04.007_bb0200","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/sj.bjp.0704073","article-title":"Inhibitory effects of cyclic AMP elevating agents on lipopolysaccharide (LPS)-induced microvascular permeability change in mouse skin","volume":"133","author":"Irie","year":"2001","journal-title":"Br J Pharmacol"},{"issue":"2","key":"10.1016\/j.vph.2015.04.007_bb0205","doi-asserted-by":"crossref","first-page":"308","DOI":"10.2165\/00003495-199039020-00009","article-title":"Dopexamine hydrochloride. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in acute cardiac insufficiency","volume":"39","author":"Fitton","year":"1990","journal-title":"Drugs"},{"issue":"4","key":"10.1016\/j.vph.2015.04.007_bb0210","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1097\/CCM.0b013e31816a091b","article-title":"Effect of dopexamine infusion on mortality following major surgery: individual patient data meta-regression analysis of published clinical trials","volume":"36","author":"Pearse","year":"2008","journal-title":"Crit Care Med"},{"issue":"11","key":"10.1016\/j.vph.2015.04.007_bb0215","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.annfar.2010.07.012","article-title":"Dopexamine test in septic shock with hyperlactatemia","volume":"29","author":"Mayeur","year":"2010","journal-title":"Ann Fr Anesth Reanim"},{"issue":"5","key":"10.1016\/j.vph.2015.04.007_bb0220","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1097\/SHK.0b013e31818909c0","article-title":"Recombinant human erythropoietin prevents lipopolysaccharide-induced vascular hyporeactivity in the rat","volume":"31","author":"di Villa Bianca","year":"2009","journal-title":"Shock"}],"container-title":["Vascular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189115000762?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189115000762?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T15:05:43Z","timestamp":1748358343000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1537189115000762"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":44,"alternative-id":["S1537189115000762"],"URL":"https:\/\/doi.org\/10.1016\/j.vph.2015.04.007","relation":{},"ISSN":["1537-1891"],"issn-type":[{"value":"1537-1891","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increased \u03b22-adrenergic vasorelaxation at the early phase of endotoxemic shock in rats","name":"articletitle","label":"Article Title"},{"value":"Vascular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vph.2015.04.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}